Celyad Oncology【CYAD】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.457

買値

0.45

売値

0.48

出来高

2,044

0.453 日の範囲 0.4845

0.212 52 週間の範囲 1.22

時価総額

18.933M

前日終値

0.465

始値

0.453

時刻

108

0.457

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

105,402

発行済株式数

41,429,000

配当利回り

PER

-2.26

1 株当たり利益 (EPS)

-0.2

歳入

102k

純利益

-8.45M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.celyad.com

本社

Mont-saint-guibert, Walloon Brabant, Bel

設立

Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker CYAD. The last closing price for Celyad Oncology was 0.47 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 1.22 €.

Celyad Oncology currently has 41,429,000 shares in issue. The market capitalisation of Celyad Oncology is 19.26 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -2.26.

Celyad Oncology Présentera au Congrès Annuel SITC 2024

Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer...

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.053	-10.3921568627	0.51	0.53	0.453	13495	0.47364378	DE
4	-0.243	-34.7142857143	0.7	0.729	0.453	33951	0.59161312	DE
12	0.147	47.4193548387	0.31	1.22	0.3	105402	0.73997577	DE
26	0.204	80.6324110672	0.253	1.22	0.212	56998	0.65158351	DE
52	0.007	1.55555555556	0.45	1.22	0.212	36975	0.57510808	DE
156	-2.808	-86.0030627871	3.265	3.295	0.212	39199	1.06758199	DE
260	-9.903	-95.5888030888	10.36	12.08	0.212	41253	3.25946516	DE

CYAD - Frequently Asked Questions (FAQ)

What is the current Celyad Oncology share price?

The current share price of Celyad Oncology is 0.457 €

How many Celyad Oncology shares are in issue?

Celyad Oncology has 41,429,000 shares in issue

What is the market cap of Celyad Oncology?

The market capitalisation of Celyad Oncology is EUR 19.26M

What is the 1 year trading range for Celyad Oncology share price?

Celyad Oncology has traded in the range of 0.212 € to 1.22 € during the past year

What is the PE ratio of Celyad Oncology?

The price to earnings ratio of Celyad Oncology is -2.26

What is the cash to sales ratio of Celyad Oncology?

The cash to sales ratio of Celyad Oncology is 184

What is the reporting currency for Celyad Oncology?

Celyad Oncology reports financial results in EUR

What is the latest annual turnover for Celyad Oncology?

The latest annual turnover of Celyad Oncology is EUR 102k

What is the latest annual profit for Celyad Oncology?

The latest annual profit of Celyad Oncology is EUR -8.45M

What is the registered address of Celyad Oncology?

The registered address for Celyad Oncology is AXIS BUSINESS PARK, RUE ANDRE DUMONT 9, MONT-SAINT-GUIBERT, WALLOON BRABANT, 1435

What is the Celyad Oncology website address?

The website address for Celyad Oncology is www.celyad.com

Which industry sector does Celyad Oncology operate in?

Celyad Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ALCYBCybergun	0.0002 € (100.00%)	26.28M
DMSBSDiagnostic Medical Systems	0.0065 € (44.44%)	2.05k
ALTROTronic s Microsystems	5.35 € (37.18%)	89
VACBSPierre & Vacances	0.0684 € (31.54%)	65.33k
ALAGOEPango SA	0.211 € (20.71%)	7.47M
MLIMLImalliance	0.35 € (-47.76%)	1.45k
BIODSBiosynex DS	0.0611 € (-45.45%)	78.48k
DRVDSDrone Volt DS	0.0004 € (-33.33%)	698.93k
ALALOAcheterLouerFR	0.0382 € (-25.83%)	375.21k
MLSMLSmalto	0.0155 € (-24.39%)	50
ATOAtos SE	0.0021 € (0.00%)	704.16M
BCPBanco Comercial Portugues SA	0.5024 € (-2.52%)	71.58M
ALCYBCybergun	0.0002 € (100.00%)	26.28M
ALVERVergnet	0.0014 € (0.00%)	22.54M
ORAOrange.	10.29 € (1.33%)	11.29M